Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

91.04
Delayed Data
As of Oct 16
 +0.37 / +0.41%
Today’s Change
55.06
Today|||52-Week Range
92.61
+45.38%
Year-to-Date
ABBV Regular Dividend: ABBV began trading ex-dividend on 10/12/17. A $0.64 dividend will be paid to shareholders of record as of 10/13/17.

Today’s Trading

Previous close90.67
Today’s open91.01
Day’s range90.56 - 91.99
Volume4,640,276
Average volume (3 months)6,002,167
Market cap$144.5B
Dividend yield2.81%
Data as of 4:00pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.66%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+12.16%
P/E ratio22.4
Price/Sales3.98
Price/Book31.15

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.14+0.28%
CELGCelgene+0.25+0.18%
GSKGlaxoSmithKline-0.15-0.37%
BMYBristol-Myers Squibb-1.64-2.51%
Data as of 4:14pm ET, 10/16/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.38
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts